Global Narcolepsy Therapeutics Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Narcolepsy Therapeutics

• 1.1 Definition of Narcolepsy Therapeutics
• 1.2 Narcolepsy Therapeutics Segment by Type
  • 1.2.1 Global Narcolepsy Therapeutics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Central nervous system stimulants
  • 1.2.3 Sodium Oxybate
  • 1.2.4 Selective Serotonin Reuptake Inhibitor (SSRI)
  • 1.2.5 Tricyclic Antidepressants
  • 1.2.6 Others
• 1.3 Narcolepsy Therapeutics Segment by Applications
  • 1.3.1 Global Narcolepsy Therapeutics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Narcolepsy With Cataplexy
  • 1.3.3 Narcolepsy Without Cataplexy
  • 1.3.4 Secondary Narcolepsy
• 1.4 Global Narcolepsy Therapeutics Overall Market
  • 1.4.1 Global Narcolepsy Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Narcolepsy Therapeutics Production (2014-2025)
  • 1.4.3 North America Narcolepsy Therapeutics Status and Prospect (2014-2025)
  • 1.4.4 Europe Narcolepsy Therapeutics Status and Prospect (2014-2025)
  • 1.4.5 China Narcolepsy Therapeutics Status and Prospect (2014-2025)
  • 1.4.6 Japan Narcolepsy Therapeutics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Narcolepsy Therapeutics Status and Prospect (2014-2025)
  • 1.4.8 India Narcolepsy Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Narcolepsy Therapeutics
• 2.3 Manufacturing Process Analysis of Narcolepsy Therapeutics
• 2.4 Industry Chain Structure of Narcolepsy Therapeutics

3 Development and Manufacturing Plants Analysis of Narcolepsy Therapeutics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Narcolepsy Therapeutics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Narcolepsy Therapeutics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Narcolepsy Therapeutics Production and Capacity Analysis
• 4.2 Narcolepsy Therapeutics Revenue Analysis
• 4.3 Narcolepsy Therapeutics Price Analysis
• 4.4 Market Concentration Degree

5 Narcolepsy Therapeutics Regional Market Analysis

• 5.1 Narcolepsy Therapeutics Production by Regions
  • 5.1.1 Global Narcolepsy Therapeutics Production by Regions
  • 5.1.2 Global Narcolepsy Therapeutics Revenue by Regions
• 5.2 Narcolepsy Therapeutics Consumption by Regions
• 5.3 North America Narcolepsy Therapeutics Market Analysis
  • 5.3.1 North America Narcolepsy Therapeutics Production
  • 5.3.2 North America Narcolepsy Therapeutics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Narcolepsy Therapeutics Import and Export
• 5.4 Europe Narcolepsy Therapeutics Market Analysis
  • 5.4.1 Europe Narcolepsy Therapeutics Production
  • 5.4.2 Europe Narcolepsy Therapeutics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Narcolepsy Therapeutics Import and Export
• 5.5 China Narcolepsy Therapeutics Market Analysis
  • 5.5.1 China Narcolepsy Therapeutics Production
  • 5.5.2 China Narcolepsy Therapeutics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Narcolepsy Therapeutics Import and Export
• 5.6 Japan Narcolepsy Therapeutics Market Analysis
  • 5.6.1 Japan Narcolepsy Therapeutics Production
  • 5.6.2 Japan Narcolepsy Therapeutics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Narcolepsy Therapeutics Import and Export
• 5.7 Southeast Asia Narcolepsy Therapeutics Market Analysis
  • 5.7.1 Southeast Asia Narcolepsy Therapeutics Production
  • 5.7.2 Southeast Asia Narcolepsy Therapeutics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Narcolepsy Therapeutics Import and Export
• 5.8 India Narcolepsy Therapeutics Market Analysis
  • 5.8.1 India Narcolepsy Therapeutics Production
  • 5.8.2 India Narcolepsy Therapeutics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Narcolepsy Therapeutics Import and Export

6 Narcolepsy Therapeutics Segment Market Analysis (by Type)

• 6.1 Global Narcolepsy Therapeutics Production by Type
• 6.2 Global Narcolepsy Therapeutics Revenue by Type
• 6.3 Narcolepsy Therapeutics Price by Type

7 Narcolepsy Therapeutics Segment Market Analysis (by Application)

• 7.1 Global Narcolepsy Therapeutics Consumption by Application
• 7.2 Global Narcolepsy Therapeutics Consumption Market Share by Application (2014-2019)

8 Narcolepsy Therapeutics Major Manufacturers Analysis

• 8.1 Addrenex Pharmaceuticals, Inc.
  • 8.1.1 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Production Sites and Area Served
  • 8.1.2 Addrenex Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Teva Pharmaceutical Industries Ltd.
  • 8.2.1 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Production Sites and Area Served
  • 8.2.2 Teva Pharmaceutical Industries Ltd. Product Introduction, Application and Specification
  • 8.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Jazz Pharmaceuticals PLC
  • 8.3.1 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Production Sites and Area Served
  • 8.3.2 Jazz Pharmaceuticals PLC Product Introduction, Application and Specification
  • 8.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Graymark Healthcare, Inc.
  • 8.4.1 Graymark Healthcare, Inc. Narcolepsy Therapeutics Production Sites and Area Served
  • 8.4.2 Graymark Healthcare, Inc. Product Introduction, Application and Specification
  • 8.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Arena Pharmaceuticals, Inc.
  • 8.5.1 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Production Sites and Area Served
  • 8.5.2 Arena Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 BIOPROJET
  • 8.6.1 BIOPROJET Narcolepsy Therapeutics Production Sites and Area Served
  • 8.6.2 BIOPROJET Product Introduction, Application and Specification
  • 8.6.3 BIOPROJET Narcolepsy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Shire
  • 8.7.1 Shire Narcolepsy Therapeutics Production Sites and Area Served
  • 8.7.2 Shire Product Introduction, Application and Specification
  • 8.7.3 Shire Narcolepsy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Ligand Pharmaceuticals, Inc.
  • 8.8.1 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Production Sites and Area Served
  • 8.8.2 Ligand Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Narcolepsy Therapeutics Market

• 9.1 Global Narcolepsy Therapeutics Market Trend Analysis
  • 9.1.1 Global Narcolepsy Therapeutics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Narcolepsy Therapeutics Regional Market Trend
  • 9.2.1 North America Narcolepsy Therapeutics Forecast 2019-2025
  • 9.2.2 Europe Narcolepsy Therapeutics Forecast 2019-2025
  • 9.2.3 China Narcolepsy Therapeutics Forecast 2019-2025
  • 9.2.4 Japan Narcolepsy Therapeutics Forecast 2019-2025
  • 9.2.5 Southeast Asia Narcolepsy Therapeutics Forecast 2019-2025
  • 9.2.6 India Narcolepsy Therapeutics Forecast 2019-2025
• 9.3 Narcolepsy Therapeutics Market Trend (Product Type)
• 9.4 Narcolepsy Therapeutics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Narcolepsy Therapeutics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List